tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksChatGPT StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksTipRanks CommunityContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsSmart PortfolioExpert CenterTipRanksAI
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
Daily Analyst Ratings
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed ToolsTry Now
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
ChatGPT Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
TipRanks Community
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

PRME Stock Latest News

Prime Medicine Announces FDA Clearance of Investigational New Drug (IND) Application for PM359 for the Treatment of Chronic Granulomatous Disease (CGD)
Press ReleasesPrime Medicine Announces FDA Clearance of Investigational New Drug (IND) Application for PM359 for the Treatment of Chronic Granulomatous Disease (CGD)
2d ago
PRME
Prime Medicine announces FDA clearance of IND application for PM359
PremiumThe Fly
Prime Medicine announces FDA clearance of IND application for PM359
2d ago
PRME
Prime Medicine to Present Preclinical Data Demonstrating Broad Potential of Prime Editing Technology at Upcoming Scientific Meetings
PremiumPress Releases
Prime Medicine to Present Preclinical Data Demonstrating Broad Potential of Prime Editing Technology at Upcoming Scientific Meetings
8d ago
PRME
Prime Medicine initiated with a Buy at Chardan
PremiumThe Fly
Prime Medicine initiated with a Buy at Chardan
9d ago
PRME
Prime Medicine initiated with a Buy at TD Cowen
PremiumThe Fly
Prime Medicine initiated with a Buy at TD Cowen
23d ago
PRME
Prime Medicine started with Outperform on ‘differentiated’ platform at Wedbush
PremiumThe FlyPrime Medicine started with Outperform on ‘differentiated’ platform at Wedbush
28d ago
PRME
Prime Medicine price target lowered to $20 from $24 at Guggenheim
PremiumThe Fly
Prime Medicine price target lowered to $20 from $24 at Guggenheim
2M ago
PRME
Prime Medicine Reports Full Year 2023 Financial Results and Provides Business Updates
PremiumPress Releases
Prime Medicine Reports Full Year 2023 Financial Results and Provides Business Updates
2M ago
PRME
Prime Medicine reports FY23 EPS ($2.18), consensus ($1.97)
PremiumThe Fly
Prime Medicine reports FY23 EPS ($2.18), consensus ($1.97)
2M ago
PRME
Prime Medicine to Participate in Upcoming Investor Conferences
PremiumPress Releases
Prime Medicine to Participate in Upcoming Investor Conferences
2M ago
PRME
Prime Medicine Announces Closing of Upsized Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
PremiumPress Releases
Prime Medicine Announces Closing of Upsized Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
2M ago
PRME
Prime Medicine Announces $150.9M Public Offering and Warrants
PremiumCompany Announcements
Prime Medicine Announces $150.9M Public Offering and Warrants
2M ago
8K
PRME
Cathie Wood’s ARK Investment bought 3.4M shares of Prime Medicine today
PremiumThe FlyCathie Wood’s ARK Investment bought 3.4M shares of Prime Medicine today
3M ago
PRME
Prime Medicine 19.2M share Spot Secondary priced at $6.25
PremiumThe Fly
Prime Medicine 19.2M share Spot Secondary priced at $6.25
3M ago
PRME
Prime Medicine Announces Pricing of Upsized Public Offering
PremiumPress Releases
Prime Medicine Announces Pricing of Upsized Public Offering
3M ago
PRME
Prime Medicine Announces Proposed Public Offering of Common Stock
PremiumPress Releases
Prime Medicine Announces Proposed Public Offering of Common Stock
3M ago
PRME
Prime Medicine $125M Spot Secondary; price range $6.25-$6.50
PremiumThe Fly
Prime Medicine $125M Spot Secondary; price range $6.25-$6.50
3M ago
PRME
Prime Medicine announces $125M common stock offering
PremiumThe Fly
Prime Medicine announces $125M common stock offering
3M ago
PRME
Prime Medicine Receives Up to $15 Million from Cystic Fibrosis Foundation to Advance Hotspot and PASSIGE™ Prime Editors for Cystic Fibrosis
PremiumPress Releases
Prime Medicine Receives Up to $15 Million from Cystic Fibrosis Foundation to Advance Hotspot and PASSIGE™ Prime Editors for Cystic Fibrosis
3M ago
PRME
Prime Medicine receives up to $15M from CF foundation
PremiumThe FlyPrime Medicine receives up to $15M from CF foundation
3M ago
PRME
Prime Medicine treatment of chronic granulomatous disease granted orphan status
PremiumThe Fly
Prime Medicine treatment of chronic granulomatous disease granted orphan status
3M ago
PRME
Prime Medicine downgraded to Hold from Buy at Stifel
PremiumThe Fly
Prime Medicine downgraded to Hold from Buy at Stifel
4M ago
PRME

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >